Â鶹´«Ã½ÊÓƵÍøÕ¾

We provide here a comparative account of the methodology and aims of CONVINCE in the context of the totality of evidence, and how this study will contribute to reaching a higher level of certainty regarding the comparative efficacy of HDF vs HD in people with end-stage kidney disease (ESKD).

ÌýFor further publications regarding this study, please see the CONVINCEÌýPublication Page.Ìý